Lecture 17-18: Interstitial Lung Disease and Pathology Flashcards
PFT shows what in interstitial lung disease
Restrictive physiology and impaired gas exchange
ILD: acute or chronic?
Chronic typically
ILD: symptoms
Nonspecific: dyspnea, dry cough
ILD: FVC & TLC, DLCO, A-a gradient
Decreased FVC and TLC with PRESERVED FEV1 / FVC ratio, decreased DLCO, increased A-a gradient
ILD: hypoxemia?
Yes
ILD: imaging dx
High resolution CT scan to visualize fibrosis
Signs of fibrosis from early –> late
Increased reticular densities, traction bronchiectasis, honeycomb changes, cysts
What does reticular densities look like? Early or late?
Increased “lines” (thickened interalveolar septum); early fibrosis
What is traction bronchiectasis?
Dilated airways pulled apart (traction) by fibrosis
Honeycomb and cysts are evidence of what stage of firbrosis
Advanced
What is the histological pattern identified for idiopathic pulmonary fibrosis? Can this be associated with other disease?
Usual interstitial pneumonia (UIP); yes, known causes of pulmonary fibrosis can look like this
Is idiopathic pulmonary fibrosis deadly? Survival length?
YES: most deadly, median survival is 2.8 years
IPF: clinical features
Subacute, insidious dyspnea, cough, rales, CLUBBING, PFT’s restrictive, impaired gas exchange (DLCO, A-a gradient)
IPF: diagnostic blood test?
Nope
IPF: dx (2 findings from two different modalities)
CT scan: interstitial lung disease and biopsy: fibrotic changes –> fibroblast foci
IPF: gross
Dense, collagenous, dilated airways with large ares of scarring
IPF: pathogenesis
Alveolar epithelial cells injured (unidentified) with PERMANENT cell death and ABNORMAL cell growth = myofibroblast –> collagen and vascular remodeling
What is a myofibroblast
Both a SM cell (contractile properties) and a fibroblast cell that produces collagen
IPF: genetics (AD or AR?)
25% of IPF patients have a family member with interstitial lung disease; AD
If someone has family members with IPF and they get IPF, what is their course like?
More aggressive and occurs at a younger age
IPF: medical tx (2) and surgical tx
Pirfenidone (blocks pro-fibrotic cytokines) and nintedanib (trile tyorsine kinase inhibitor); lung transplant
Pirfenidone blocks what two factors?
TGF-beta and PDGF (platelet derived GF)
Nintedanib inhibits what three factors?
VEGF (vascular endothelial GF), FGF (fibroblast GF), PDGF
Lung transplant survival
5 year = 50%